Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors
  • Library

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, China
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Our sub-categories
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2025
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Galderma Insights
    • Podcasts
  • Innovation
    • Bringing innovation to life
    • Partnerships
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors
You searched for: «【✈️ Telegram ID: KPU77】 대성피 성인 피시방 안전 보장 100% 알거래 중개소 리스트 - 용인»
Results 36 - 40 of 155
Page 8 of 31
  1. Media
  2. Newsroom

Galderma Received FDA Approval of Differin® (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation

- Differin® 0.1% New Lotion Formulation Further Expands Galderma Acne Portfolio -

Camp Wonder

  1. Media
  2. Newsroom

International Congress of Dermatology 2025: Galderma’s Scientific Presentations

 

Galderma will present data from across its Therapeutic Dermatology portfolio at the XIV International Congress of Dermatology (ICD), taking place in Rome, Italy, on June 18-21, 2025, including updates on its investigations in acne, non-melanoma skin cancer, and prurigo nodularis.  

 

  1. Media
  2. Newsroom

Nestlé Skin Health Invests $46 Million in Factory Extension in Canada

Lausanne, 22 January 2016 – Nestlé Skin Health, global leader focused on enhancing the quality of life by delivering science-based solutions for the health of the skin, hair and nails, today announced that it is investing $ 46 Million (CAD) to extend the capacity of its Canadian factory located in Baie d’Urfé, Québec. 

  1. Media
  2. Newsroom

Aging Experts Join Nestlé Skin Health at IAGG 2017 to Shine a Spotlight on Skin Health as Critical Pathway to Healthy Aging

SAN FRANCISCO, July 25, 2017 – Two of the world’s preeminent experts on aging joined Nestlé Skin Health yesterday at the International Association of Gerontology and Geriatrics World Congress (IAGG) to highlight the critical role of skin wellness in successful aging.

Results 36 - 40 of 155
Page 8 of 31

Pagination

  • Previous page Previous Page
  • Next page Next Page
  1. Home
  2. Search results

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2026

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back